Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Review paper

Towards elimination of viral hepatitis in the Czech Republic, Hungary, Poland and Slovakia: insights from the Viral Hepatitis Prevention Board (VHPB)

Robert Flisiak
1
,
Frankova Sona
2
,
Sakshi Jindal
3
,
Viktor Aster
4
,
Bela Hunyady
5
,
Mihaly Makara
6
,
Pavol Kristian
7
,
Danica V. Stanekova
8
,
Dorota Zarębska-Michaluk
9
,
Sara Valckx
3
,
Greet Hendrickx
3
,
Pierre Van Damme
3
,
Mojca Maticic
3, 10

  1. Department of Infectious Diseases, Medical University of Białystok, Białystok, Poland
  2. Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
  3. Viral Hepatitis Prevention Board, Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium
  4. Department of Infectious and Tropical Diseases, Charles University and Bulovka University, Prague, Czech Republic
  5. University of Pécs, First Department of Internal Medicine, Pécs, Hungary
  6. Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Outpatient Clinic, Szent László Hospital Budapest, Budapest, Hungary
  7. Department of Infectology and Travel Medicine, Faculty of Medicine, P.J. Šafárik University, and L. Pasteur University Hospital, Košice, Slovakia
  8. St. Elizabeth University of Health & Social Work, Bratislava, Slovakia
  9. Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland
  10. University Medical Centre Ljubljana, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Clin Exp HEPATOL 2026; 12, 1
DOI: https://doi.org/10.5114/ceh.2026.158833
Online publish date: 2026/01/28
Article file
- Towards elimination.pdf  [0.13 MB]
Get citation
 
PlumX metrics:
 
1. VHPB. Elimination of Viral Hepatitis in the Czech Republic, Hungary, Poland and Slovakia: Learnt and the Way Forward (29-30 October 2024, Prague, Czech Republic). VHPB 2024. Available from: https://www.vhpb.org/meeting/vhpb-regional-meeting-elimination-of-viral-hepatitis-in-the-czech-republic-hungary-poland-and-slovakia-lessons-learnt-and-the-way-forward/
2. Healthcare expenditure statistics – overview. Eurostat. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_expenditure_statistics_-_overview
3. Population change – Demographic balance and crude rates at national level. Eurostat. Available from: https://ec.europa.eu/eurostat/databrowser/view/DEMO_GIND__custom_10293339/bookmark/table?lang=en&bookmarkId=cdf29d2c-8d15-4f2c-96b6-a51f8a389103
4. Rapid Risk Assessment: Multi-country outbreak of hepatitis A in the EU/EEA. ECDC. 2025. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-multi-country-outbreak-hepatitis-eueea
5. Vaccine Scheduler. ECDC. Available from: https://vaccine-schedule.ecdc.europa.eu/
6. European Centre for Disease Prevention and Control. Prevention of hepatitis B and C in the EU/EEA. LU: Publications Office; 2024. Available from: https://data.europa.eu/doi/10.2900/703244
7. Hepatitis – number of chronic hepatitis B-infected persons treated. WHO. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hepatitis---number-of-chronic-hepatitis-b-infected-persons-treated
8. Razavi HA, Waked I, Qureshi H, et al. Number of people treated for hepatitis C virus infection in 2014–2023 and applicable lessons for new HBV and HDV therapies. J Hepatol 2025; 83: 329-347.
9. Health system summaries. WHO Regional Office for Europe. Available from: https://eurohealthobservatory.who.int/publications/health-systems-reviews/health-system-summaries
10. Akčné plány – Portál úradov. UVZ SR. Available from: https://www.uvzsr.sk/web/uvz/akcne-plaby-epidemiologia
11. Casna diagnostika lecba chronicke virove hepatitidy C (VHC). KDP UZIS. Available from: https://kdp.uzis.cz/res/guideline/ 25-casna-diagnostika-lecba-chronicke-virove-hepatitidy-c-vhc-final.pdf
12. Horváth G, Gerlei Z, Gervain J, et al. Diagnosis and antiviral therapy of hepatitis B and D – Hungarian Consensus Guideline. Cent Eur J Gastroenterol Hepatol 2019; 5: 185-197.
13. Hunyady B, Gerlei Z, Gervain J, et al. A hepatitis C-vírus-fertőzés szűrése, diagnosztikája, antivirális terápiája, kezelés utáni gondozása: Magyar konszenzusajánlás. Cent Eur J Gastroenterol Hepatol 2021; 7: 7-21.
14. Tomasiewicz K, Flisiak R, Jaroszewicz J, et al. Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023. Clin Exp Hepatol 2023; 9: 1-8.
15. Surveillance Atlas of Infectious Diseases. ECDC. Available from: https://atlas.ecdc.europa.eu/public/index.aspx
16. Korzeniewski K, Shkilna M, Huk M, et al. Ukrainian war refugees and migrants in Poland: implications for public health. J Travel Med 2023; 31: taad119.
17. Flisiak R, Zarębska-Michaluk D, Martonik D, et al. Treatment of hepatitis C virus infections among patients of Ukrainian origin during the influx of war refugees to Poland. J Clin Med 2024; 13: 7641.
18. Nitsch-Osuch A, Pawlus B, Pawlak M, et al. Decreasing vaccination coverage against hepatitis B and tuberculosis in newborns. In: Pokorski M (Ed.). Trends in Biomedical Research. Springer International Publishing, Cham 2020; 99-105. Available from: https://doi.org/10.1007/5584_2019_446
19. Kurpas D, Stefanicka-Wojtas D, Soll-Morka A, et al. Vaccine hesitancy and immunization patterns in Central and Eastern Europe: sociocultural, economic, political, and digital influences across seven countries. Risk Manag Healthc Policy 2025; 18: 1911-1934.
20. Buchancová J, Švihrová V, Legáth Ľ, et al. Occupational viral hepatitis in the Slovak and the Czech Republic. Cent Eur J Public Health 2013; 21: 92-97.
21. European Centre for Disease Prevention and Control. Monitoring of the responses to the hepatitis B and C epidemics in EU/EEA countries, 2023. Publications Office, LU 2024. Available from: https://data.europa.eu/doi/10.2900/49867
22. Fraňková S, Urbánek P, Husa P, et al. Chronic hepatitis C in the Czech Republic: forecasting the disease burden. Cent Eur J Public Health 2019; 27: 93-98.
23. Mravčík V, Janíková B, Thanki D, et al. Informed implementation practice – formative research of a mobile drug consumption room in Brno, Czech Republic. Harm Reduct J 2025; 22: 106.
24. ClinConnect. Early detection of HCV in injection drug users. 2020. Available from: https://clinconnect.io/trials/NCT06431945
25. Frankova S, Jandova Z, Jinochova G, et al. Therapy of chronic hepatitis C in people who inject drugs: focus on adherence. Harm Reduct J 2021; 18: 69.
26. Tsaneva-Damyanova DT, Georgieva LH. Epidemiology pattern, prevalent genotype distribution, fighting stigma and control options for hepatitis D in Bulgaria and other European countries. Life 2023; 13: 1115.
27. Werling K, Hunyady B, Makara M, et al. Hepatitis C screening and treatment program in Hungarian prisons in the era of direct acting antiviral agents. Viruses 2022; 14: 308.
28. Pelczarska A, Gruszka J, Skassa E, et al. The cost-effectiveness of universal HCV screening strategies in Poland. Value Health 2024; 27: S53-54.
29. Tronina O, Panczyk M, Zarębska-Michaluk D, et al. Global elimination of HCV – why is Poland still so far from the goal? Viruses 2023; 15: 2067.
30. Petkevičienė J, Voeller A, Čiupkevičienė E, et al. Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets. BMC Public Health 2024; 24: 1055.
31. Dybowska D, Zarębska-Michaluk D, Rzymski P, et al. Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders. World J Gastroenterol 2023; 29: 4085-4098.
32. Włosowicz A, Zmudka KJ, Pałczyńska-Gwiazdowicz E, et al. Prevalence of HDV infections in Poland based on the experience of a single center in Silesia and literature research. Clin Exp Hepatol 2024; 10: 137-143.
33. Zarębska-Michaluk D, Brzdęk M, Dobrowolska K, et al. Prevalence of hepatitis D virus in chronic hepatitis B patients: findings from Poland. Adv Med Sci 2025; 70: 277-283.
34. Genowska A, Zarębska-Michaluk D, Tyszko P, et al. Trends of infections and mortality due to hepatitis B virus (2005–2022) and the potential impact of the COVID-19 pandemic: a population-based study in Poland. Clin Exp Hepatol 2023; 9: 286-296.
35. Hockicková I, Hockicko J, Jarčuška P, et al. Impact of the removal of treatment barriers on the microelimination of chronic hepatitis C in Slovak prisons: experience from real-life settings. Clin Exp Hepatol 2025; 11: 271-278.
36. Kristian P, Hockicková I, Hatalová E, et al. Is Slovakia almost a hepatitis D free country? Viruses 2023; 15: 1695.
37. Viral hepatitis in Europe’s Beating Cancer Plan – prevention and control of viral hepatitis as cancer prevention opportunities (27-28 March 2025, Antwerp, Belgium). VHPB 2025. Available from: https://www.vhpb.org/meeting/viral-hepatitis-in-europes-beating-cancer-plan-prevention-and-control-of-viral-hepatitisas-cancer-prevention-opportunities-27-28-march-2025-antwerp-belgium/
38. Werling K, Hunyady B, Makara M, et al. Hepatitis C screening and treatment program in Hungarian prisons in the era of direct acting antiviral agents. Viruses 2022; 14: 308.
39. Pyziak-Kowalska KA, Horban A, Bielecki M, et al. Missed opportunities for diagnosing viral hepatitis C in Poland. Results from routine HCV testing at the emergency department in the Hospital for Infectious Diseases in Warsaw. Clin Exp Hepatol 2019; 5: 294-300.
40. Marcinkiewicz A, Walusiak-Skorupa J, Wdówik P, et al. Guidance for the occupational medicine service regarding the prevention of hepatitis C and HIV infection in Poland. Med Pr 2024; 75: 485-494.
41. Standard diagnostic and therapeutic procedure: comprehensive management of the patient with opioid dependence. ADZPO. Available from: https://adzpo.sk/sk/adzpo-aktualne-cislo/1655-standardny-diagnosticky-a-terapeuticky-postup-komplexny-manazment-pacienta-so-zavislostou-od-opioidov
42. Flisiak R, Zarębska-Michaluk D, Frankova S, et al. Is elimination of HCV in 2030 realistic in Central Europe. Liver Int 2021; 41 (S1): 56-60.
43. Flisiak R, Zarębska-Michaluk D, Ciupkeviciene E, et al. HCV elimination in Central Europe with particular emphasis on microelimination in prisons. Viruses 2022; 14: 482.
44. Tarján A, Dudás M, Wiessing L, et al. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary – an expanding public health burden. Int J Drug Policy 2017; 41: 1-7.
45. Cazalis A, Lambert L, Auriacombe M. Stigmatization of people with addiction by health professionals: current knowledge. A scoping review. Drug Alcohol Depend Rep 2023; 9: 100196.
46. Frankova S, Jandova Z, Jinochova G, et al. Therapy of chronic hepatitis C in people who inject drugs: focus on adherence. Harm Reduct J 2021; 18: 69.
47. European Centre for Disease Prevention and Control. Progress towards reaching the Sustainable Development Goals related to HIV, viral hepatitis, sexually transmitted infections and tuberculosis in the EU/EEA: 2024 progress report (2022–2023 data). Publications Office, LU 2025. Available from: https://data.europa.eu/doi/10.2900/8145794
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Bentus.